Finding hope by expanding the frontiers of therapy
We design ground-breaking therapies through precision-targeting of membrane receptors to bring hope to people living with autoimmune diseases
Latest News
Robert Glanzman,
Chief Medical Officer
Board-certified neurologist and Fellow of the American Academy of Neurology with over 20 years experience…
Dr. Jack Antel joins our clinical advisory board
Dr. Antel is an internationally acclaimed clinical neurologist and thought leader who coordinates the multiple…
Formation of a clinical advisory board
The clinical advisory board will guide the company in the development of its autoimmune programs…
Our investors
... share our passion for discovering and developing breakthrough science to bring hope to people’s lives
